Prelude Capital Management, LLC Meridian Bioscience Inc Transaction History

Prelude Capital Management, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$31.15 - $33.39 $511,981 - $548,798	-16,436 Reduced 21.62%	59,592 $1.98 Million
Q3 2022 Nov 14, 2022	BUY	$30.9 - $33.55 $2.35 Million - $2.55 Million	76,028 New	76,028 $2.4 Million
Q4 2020 Feb 16, 2021	SELL	$15.73 - $21.66 $5,002 - $6,887	-318 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$13.54 - $26.41 $2,708 - $5,282	200 Added 169.49%	318 $5,000
Q2 2020 Aug 14, 2020	SELL	$7.84 - $23.29 $16,511 - $49,048	-2,106 Reduced 94.69%	118 $3,000
Q1 2020 May 15, 2020	BUY	$5.57 - $11.5 $12,259 - $25,311	2,201 Added 9569.57%	2,224 $19,000
Q4 2019 Feb 14, 2020	BUY	$7.9 - $10.14 $181 - $233	23 New	23 $0
Q3 2019 Nov 14, 2019	SELL	$9.17 - $12.01 $102,584 - $134,355	-11,187 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$10.88 - $17.6 $121,714 - $196,891	11,187 New	11,187 $133,000
Q1 2019 May 15, 2019	SELL	$15.51 - $17.61 $11,663 - $13,242	-752 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$14.52 - $19.72 $7,405 - $10,057	-510 Reduced 40.41%	752 $13,000
Q3 2018 Nov 14, 2018	BUY	$14.85 - $16.35 $668 - $735	45 Added 3.7%	1,262 $19,000
Q2 2018 Aug 14, 2018	SELL	$13.8 - $16.8 $71,911 - $87,544	-5,211 Reduced 81.07%	1,217 $19,000
Q1 2018 May 15, 2018	BUY	$13.8 - $16.2 $48,796 - $57,283	3,536 Added 122.27%	6,428 $91,000
Q4 2017 Feb 14, 2018	SELL	$13.55 - $15.8 $112,573 - $131,266	-8,308 Reduced 74.18%	2,892 $40,000
Q3 2017 Nov 14, 2017	BUY	$13.45 - $14.35 $150,640 - $160,720	11,200	11,200 $160,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.